Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Moderate Allocation
  • Asset Class: Mixed Allocation
  • Geographic Focus: Multi

NB PHARMAFUND FI

+ Add to Watchlist

PHARMFD:SM

20.26 EUR 0.03 0.14%

As of 00:59:30 ET on 03/26/2015.

Snapshot for NB PHARMAFUND FI (PHARMFD)

Year To Date: +17.17% 3-Month: +17.51% 3-Year: +23.65% 52-Week Range: 14.08 - 20.82
1-Month: +4.31% 1-Year: +39.04% 5-Year: +14.13% Beta vs MSGUPHA: 0.83

Mutual Fund Chart for PHARMFD

No chart data available.
  • PHARMFD:SM 20.26
  • 1M
  • 1Y
Interactive PHARMFD Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for PHARMFD

NB PHARMAFUND FI is an open-end fund incorporated in Spain. The Fund's objective is capital accumulation. The Fund invests in international equity securities that are engaged in the pharmaceutical and biotechnology sectors.

Inception Date: 05-15-1997 Telephone: 34-90-212-3252
Managers: -
Web Site: www.esgestion.com

Fundamentals for PHARMFD

NAV (on 2015-03-26) 20.26
Assets (M) (on 2015-03-26) 7.82
Fund Leveraged N
Minimum Investment 10.00
Minimum Subsequent Investment -

Dividends for PHARMFD

No dividends reported

Fees & Expenses for PHARMFD

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 2.25
Redemption Fee 0.00
12b1 Fee -
Expense Ratio -

Top Fund Holdings for PHARMFD

Filing Date: 01/31/2015
Name Position Value % of Total
SGLT 0 04/10/15 715 714,685 10.257%
Amgen Inc 3,809 513,647 7.372%
Allergan Inc/United States 2,550 495,185 7.107%
Novartis AG 5,200 451,110 6.475%
Pfizer Inc 16,000 442,831 6.356%
Actavis plc 1,800 424,915 6.099%
Eli Lilly & Co 5,050 322,026 4.622%
Bristol-Myers Squibb Co 5,940 317,070 4.551%
Mylan NV 6,721 316,377 4.541%
Bayer AG 2,420 309,881 4.448%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil